Compliance & EnforcementFalse Claims Act
ArchiveFalse Claims Act
3,592 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Non-Parties Duck Subpoenas Seeking Minimally Relevant Information; United States District Court for the Western District of North Carolina No. 3:16-CV-00750-GCM, U.S. ex rel. Daniel Hayes M.D. v. Charlotte Mecklenburg Hospital Authority
I’m a Relator, Not a Doctor! Lack of Billing, Medical Knowledge Dooms Medicare Fraud Claims; United States District Court for the Middle District of Florida No. 8:16-cv-961-T-27AEP, U.S. ex rel. Delia Bell v. Cross Garden Care Center LLC, et al.
District Court Issues Rare Rebuke Denying DOJ’s Belated Motion to Intervene
The False Claims Act and Health Care: 2020 Recoveries and 2021 Outlook
FCA Retaliation Claim Not Covered by Relator’s Arbitration Agreement; United States District Court for the Middle District of Tennessee, Nashville Division, No. 3:13-CV-01025, U.S. ex rel. Paul Dorsa v. Miraca Life Sciences Inc.
Sixth Circuit Finds No Appealable Issue in Denial of Motion to Dismiss; United States Court of Appeals for the Sixth Circuit No. 20-5007, U.S. ex rel. Paul Dorsa v. Miraca Life Sciences Inc.
CMS Statement Clarifies Agency’s View that the Stark Law Final Rule is Effective
Qui Tam Quarterly – Risky Business: Health Care Investments Pose Acute False Claims Act Risk for Private Equity
Bench Trial Needed to Determine Whether Government Waited Too Long to Enforce Civil Penalties; United States Court of Appeals for District of Columbia Circuit No. 19-5070, U.S. v Douglas F. Greer, et al.
Malicious Prosecution Case Should Be Handled in District Where Underlying Qui Tam was Filed; United States District Court for the Southern District of West Virginia, No. 2:20-cv-00639, Marietta Area Healthcare Inc., et al. v. Michael A. King, et al.
Multiple Motions to Compel Discovery Best Resolved by Original Court; United States District Court for the Western District of Missouri, Western Division, No. 21-MC-09005-SRB. U.S. ex rel. Chris Purcell, et al. v. Gilead Sciences Inc.
SCOTUS Rejects Care Alternatives’ Petition to Review Court Split on Objective Falsity
Private Equity Firms—New(ish) FCA Targets?
Difference Between CMS Conditions of Participation and Conditions of Payment Not Dispositive to Materiality; United States District Court for the Eastern District of Pennsylvania No. 16-683, U.S., et al. ex rel. Timothy Sirls v. Kindred Healthcare Inc., et al.
Relator Failed to Show Employer Knew He Engaged in Protected Activity; United States District Court for the Middle District of Florida, Tampa Division, No. 8:14-cv-778-T-33AAS, Darius Clarke M.D., et al. v. HealthSouth Corporation, et al.
Supreme Court Declines Request to Address False Claims Act Liability For Medically Unnecessary Services
Supreme Court Declines To Clarify the Standard for Proof of Falsity Under the False Claims Act
Relator’s SAC IDs False Claims and Statements in Alleged Financial “Recycling” Scheme; United States District Court for the District of Arizona No. CV-18-8040-PCT-DGC, U.S. ex rel. Gregory Kuzma v. Northern Arizona Healthcare Corporation, et al.
A Difference of Opinion Remains: The Third Circuit’s Rejection of an “Objective Falsity” Requirement for FCA Liability Stands After the Supreme Court Denies Certiorari
Keep reading
